Skip to main content
. 2020 Feb 19;12(4):3371–3387. doi: 10.18632/aging.102817

Figure 1.

Figure 1

Relationship between immune and stromal scores and EC clinical and pathological data. (A, B) Distribution of immune and stromal scores of EC grades. (C, D) Distribution of immune and stromal scores of EC pathologic type, including endometrioid cancer, serous cancer and mix type. (E, F) Distribution of immune and stromal scores of new tumor event after initial treatment of EC.